Business Standard

Biological E slashes Corbevax prices by 70% to Rs 250 a dose for pvt mkt

End user would now need to pay Rs 400 per jab including the administration charge to get the shot at a private vaccination centre; move aimed at benefiting children

Biological E slashes Corbevax prices by 70% to Rs 250 a dose for pvt mkt
Premium

Sohini Das Mumbai
Biological E Limited (BE) has reduced the price of its Covid-19 vaccine Corbevax by 70 percent to Rs 250 per dose inclusive of taxes for the private market. Now, the end user would need to pay Rs 400 per dose including the administration charge to get the shot at a private vaccination center.

The company said that it has lowered the price of the vaccine to make it more affordable and help increase the reach to protect maximum number of children against the virus. "The decision comes within weeks of Biological E Limited receiving Emergency Use Authorisation (EUA) for children

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in